News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
289–324
Matches
1986
Sources here
19
Companies here
18
Search results Stored financial headlines

Active search

1986 matching headlines

Ticker or company: SIOMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Biomea Fusion Trial Tests Obesity Drug Combo Beyond Weight Loss

Biomea Fusion has dosed the first patient in a new arm of its OPAL study, evaluating icovamenib in combination with low-dose semaglutide for overweight or obese adults without type 2 diabetes. The study, in collaboration with the University of Leicester, aims to assess whether …

BMEA main company
Sharemaestro market context Price below Trend Line 52 weeks -27.9% · Next-week setup negative 44.3% BMEA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Biomea Fusion Initiates OPAL Study Arm of Icovamenib Plus Low-Dose Semaglutide in Obesity Research

Biomea Fusion has initiated a new arm of its OPAL study to evaluate the combination of its investigational drug, icovamenib, with low-dose semaglutide for obesity and metabolic health. This randomized, double-blind trial, conducted with the University of Leicester, will enroll 64 participants to assess …

BMEA main company
Sharemaestro market context Price below Trend Line 52 weeks -27.9% · Next-week setup negative 44.3% BMEA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Biomea Fusion Announces First Patient Dosed in OPAL Study

Biomea Fusion has announced the dosing of the first patient in a new arm of its OPAL study, evaluating icovamenib in combination with low-dose semaglutide for overweight or obese individuals without type 2 diabetes. The study aims to assess whether adding icovamenib can enhance …

BMEA main company
Sharemaestro market context Price below Trend Line 52 weeks -27.9% · Next-week setup negative 44.3% BMEA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Professional Diversity Network, Inc. SEC Filing (Aug 13, 2026)

This article announces that Professional Diversity Network, Inc. (IPDN) had an SEC filing (Form EFFECT) on August 13, 2026, which was accepted by the SEC EDGAR system at 6:32 AM on the same day. The filing pertains to a Notice of Effectiveness for an …

IPDN main company
Sharemaestro market context Price below Trend Line 52 weeks -87.9% · Next-week setup negative 41.5% IPDN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mizuho Financial Group (FVN) reports 11,000-share holding in Future Vision II

Mizuho Financial Group, Inc. has reported a passive ownership stake of 11,000 common shares, representing 0.1% of the class, in Future Vision II Acquisition Corp. The shares are directly held by Mizuho Securities USA LLC, with Mizuho Financial Group and its other entities being …

FVN main company
Sharemaestro market context Trend signal active 52 weeks +11.2% FVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Allison Transmission Holdings, Inc. Stock 12‑Month Price Target Raised to $144.14, Implies 17% Upside

The average 12-month price target for Allison Transmission Holdings, Inc. stock has increased to $144.14 from $138.78, according to 7 analysts, suggesting a 17% potential upside from its August 12 closing price. The consensus rating from 10 analysts remains "Buy," with 5 Buy and …

ALSN main company
Sharemaestro market context Trend signal started 52 weeks +42.1% ALSN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Dimensional Fund Advisors LP Acquires Shares of 216,140 BitMine Immersion Technologies, Inc. $BMNR

Dimensional Fund Advisors LP has acquired 216,140 shares of BitMine Immersion Technologies (NYSE:BMNR) in the first quarter, totaling approximately $4.28 million. Other institutional investors also adjusted their holdings in BMNR, while analyst ratings remain mixed with a "Moderate Buy" consensus but recent target price …

BMNR main company
Sharemaestro market context Price below Trend Line 52 weeks -66.2% · Next-week setup positive 55.5% BMNR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Usio earnings beat by $0.02, revenue topped estimates

Usio (NASDAQ: USIO) reported its second-quarter earnings, beating analyst EPS estimates by $0.02 with an EPS of $0.010, compared to an expected $-0.010. The company also surpassed revenue estimates, bringing in $23.68M against a consensus of $23.67M. Usio's stock has shown strong performance, rising …

USIO main company
Sharemaestro market context Trend signal active 52 weeks +81.6% · Next-week setup negative 40.9% USIO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Biomea Fusion Inc (BMEA) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Biomea Fusion Inc (BMEA), detailing analyst ratings and price targets. Seven analysts have given BMEA a "Buy" rating with a target price of $6.50, representing a significant upside. The report also includes past and projected EPS figures …

BMEA main company
Sharemaestro market context Price below Trend Line 52 weeks -27.9% · Next-week setup negative 44.3% BMEA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

National Vision Holdings Delivers 2% Revenue Growth in Q2 2026

National Vision Holdings (NASDAQ: EYE) reported adjusted diluted EPS of $0.25 on $486.4M revenue for Q2 2026, marking a 2.5% year-over-year increase. Despite a modest increase and mixed market reaction, the company achieved $12.4M in net income and 3.4% comparable store sales growth. Management …

EYE main company
Sharemaestro market context Price below Trend Line 52 weeks -22.3% EYE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

National Vision Posts Revenue Increase, Stronger Profitability in Q2

National Vision Holdings, Inc. reported a significant increase in net revenue and stronger profitability for Q2 and year-to-date 2026, driven by new store sales, unearned revenue timing, and adjusted comparable store sales growth. The company highlighted strategic initiatives such as a new unified e-commerce …

EYE main company
Sharemaestro market context Price below Trend Line 52 weeks -22.3% EYE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

National Vision Holdings, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:EYE) 2026-08-12

National Vision Holdings, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Pivot to Quality of Sale and Unified Commerce Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why …

EYE main company
Sharemaestro market context Price below Trend Line 52 weeks -22.3% EYE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Immersion (NASDAQ:IMMR) Major Shareholder Sells 200,000 Shares of Stock

Major shareholder Toro 18 Holdings Llc sold 200,000 shares of Immersion (NASDAQ:IMMR) stock for over $1 million, reducing its stake by 12.95%. Despite the sale, Immersion recently reported strong quarterly earnings, beating revenue and EPS estimates. The company also pays a quarterly dividend and …

IMMR main company
Sharemaestro market context Trend signal active 52 weeks +9.4% · Next-week setup negative 43.2% IMMR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

National Vision Holdings Inc (EYE) (Q2 2026) Earnings Call Highlights: Margin Expansion and ...

National Vision Holdings Inc. (EYE) reported a 2.5% increase in net revenue and a 2.2% rise in adjusted comparable store sales for Q2 2026, alongside a significant 140 basis point expansion in adjusted operating margin to 6.3%. Despite a 4.9% decline in customer traffic, …

EYE main company
Sharemaestro market context Price below Trend Line 52 weeks -22.3% EYE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

USIO: Q2 revenue up 19% year-over-year; guidance raised to 14%-16% growth for 2026

USIO announced a 19% year-over-year revenue growth in Q2, with significant increases across its Card, ACH, and Output Solutions. The company's adjusted EBITDA more than doubled, and it has raised its 2026 revenue growth guidance to 14%-16%, attributing this to new product introductions and …

USIO main company
Sharemaestro market context Trend signal active 52 weeks +81.6% · Next-week setup negative 40.9% USIO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SION ALERT: Investigation Launched into Sionna Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm

Robbins Geller Rudman & Dowd LLP has initiated an investigation into Sionna Therapeutics, Inc. (NASDAQ: SION) following a significant drop in its stock price. The investigation stems from the company's announcement on August 10, 2026, that its SION-719 Phase 2a trial failed to meet …

SION main company
Sharemaestro market context Trend signal ended 52 weeks -73.5% · Next-week setup positive 65.1% SION stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings call transcript: Usio tops Q2 2026 profit view, lifts revenue outlook

Usio (USIO) exceeded Q2 2026 profit expectations and slightly beat revenue forecasts, reporting earnings of $0.01 per share against an estimated loss of $0.01, and revenue of $23.68 million. The company raised its full-year revenue growth outlook to 14%-16% and saw its shares jump …

USIO main company
Sharemaestro market context Trend signal active 52 weeks +81.6% · Next-week setup negative 40.9% USIO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Usio Inc (USIO) Q2 Earnings and Revenues Top Estimates

Usio Inc (USIO) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to a loss of $0.01 per share a year ago. These figures are adjusted for non-recurring items. This …

USIO main company
Sharemaestro market context Trend signal active 52 weeks +81.6% · Next-week setup negative 40.9% USIO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Praxis Precision Medicines (NASDAQ:PRAX) Reaches New 12-Month High - Here's Why

Praxis Precision Medicines (NASDAQ:PRAX) recently hit a new 52-week high of $382.97, driven by positive analyst sentiment, including maintained "Buy" ratings and high price targets from HC Wainwright and RBC. The company beat quarterly EPS expectations and is anticipated to have significant catalysts in …

PRAX main company
Sharemaestro market context Trend signal active 52 weeks +652.0% · Next-week setup positive 58.4% PRAX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Usio (NASDAQ: USIO) returns to profit as Q2 2026 revenue hits $23.7M

Usio (NASDAQ: USIO) reported a return to profitability in Q2 2026, with net income of $280,080 compared to a net loss in the prior year, as revenue grew 19% to $23.7 million. This growth was driven by strong performance in ACH, credit card processing, …

USIO main company
Sharemaestro market context Trend signal active 52 weeks +81.6% · Next-week setup negative 40.9% USIO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vishay Precision Group (VPG) Q2 2026 Earnings Call Transcript

Vishay Precision Group (VPG) reported strong Q2 2026 orders driven by AI-related markets, resulting in a consolidated book-to-bill ratio of 1.14. Despite a $3 million revenue impact from ERP system delays and foreign exchange headwinds, the company maintained its cost reduction plan and projects …

VPG main company
Sharemaestro market context Trend signal active 52 weeks +153.6% VPG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Intrusion’s VigilAigent Acquisition Adds About $3.5M in Annual Recurring Revenue

Intrusion Inc. (NASDAQ:INTZ) reported Q2 2026 revenue of $1.5 million, a 64% sequential increase but a 22% year-over-year decrease due to delays in a U.S. government contract. The company completed the acquisition of VigilAigent, which adds approximately $3.5 million in annual recurring revenue and …

INTZ main company
Sharemaestro market context Price below Trend Line 52 weeks -63.4% · Next-week setup negative 37.9% INTZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Gray Television Exceeds Q2 Expectations With 8.7% Revenue Hike

Gray Television reported an 8.7% year-over-year revenue increase in Q2, surpassing expectations, driven by political advertising, integration of new stations, and digital ad growth. The company's Q2 operating margin also improved to 16.2% from 10.6% last year. Furthermore, Gray's revenue guidance for the next …

GTN main company
Sharemaestro market context Price above Trend Line 52 weeks -8.0% · Next-week setup negative 41.1% GTN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context